Dr Reddys Laboratories Share Price Today - Live Blog for October 23, 2025

The share price of Dr Reddys Laboratories Ltd plunged by -0.00%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,281.60, but investors are assessing whether this is a temporary dip or a long-term trend.

Dr Reddys Laboratories Ltd witnessed a substantial 0.20% increase in its share price and is currently trading at ₹1,280.10. This remarkable performance has caught the eye of investors.

With a -0.24% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,278.55. The stock is currently trading at a PE of 18.7400, while the industry PE is 35.3139, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd's share price rallied by 0.02%, reaching the current market price of ₹1,281.00. This surge is indicative of the stock's recent positive performance.

Dr Reddys Laboratories Ltd observed a -0.24% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,280.40. The stock has a PE ratio of 18.7400, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.01% increase and currently trading at ₹1,283.50 per share. This upward trajectory is turning heads in the market.

After a -0.10% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,283.10. The stock has a PE ratio of 18.7400, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

With a remarkable 0.01% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,284.45. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.7400, while the industry's PE ratio is 35.3139.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.06%, signalling a challenging period. Currently trading at ₹1,282.00, this stock has caught the eye of bargain hunters, who may be considering their entry points.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.32%, signalling a challenging period. Currently trading at ₹1,280.85, this stock has caught the eye of bargain hunters, who may be considering their entry points.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.04% recently. As of now, this stock is actively trading at a current market price of ₹1,284.00 per share, attracting attention from investors.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.18% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,283.25 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.47%, with its current market value per share resting at ₹1,281.45. This development highlights the stock's appeal to investors.

Dr Reddys Laboratories Ltd's share price rallied by 0.14%, reaching the current market price of ₹1,275.70. This surge is indicative of the stock's recent positive performance.

Dr Reddys Laboratories Ltd experienced a -0.37% downturn in its share price, and it's currently trading at ₹1,273.65. This situation is generating interest among value investors who are evaluating the stock's potential.

Dr Reddys Laboratories Ltd shares experienced a -0.26% reduction, with the current market price at ₹1,280.00. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.11%, and as of now, it's trading at ₹1,283.00 per share. This upward trajectory is attracting keen interest from investors.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.21% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,278.55 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.21% increase and currently trading at ₹1,278.55 per share. Investors are taking notice of this upward momentum.

With a -0.15% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,275.70. Investors should examine the factors driving this decline. The stock's PE ratio is 18.7400, whereas the industry PE ratio stands at 35.3139.

Dr Reddys Laboratories Ltd share price has declined by -0.15%, and it's currently trading at ₹1,275.70. The stock maintains a PE of 18.7400, while the industry PE is 35.3139, prompting discussions about its valuation.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.15% drop, and it's now trading at ₹1,275.70 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.11% boost, with the current market value at ₹1,277.30 per share. This surge has not gone unnoticed by investors.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.16%, signalling a challenging period. Currently trading at ₹1,276.00, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Dr Reddys Laboratories Ltd's share price has dropped by -0.42%, a development that warrants careful analysis. Presently trading at ₹1,279.40, investors are assessing whether this presents an opportunity or a risk.

With a -0.04% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,283.00. This development raises questions about the factors behind the decline. The stock's PE ratio is 18.7400, while the industry PE is 35.3139.

Demonstrating a commendable 0.42% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,284.60. In terms of valuation, the stock maintains a PE ratio of 18.7400, while the industry PE ratio stands at 35.3139.

With a -2.20% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,278.30. The stock is currently trading at a PE of 18.7400, while the industry PE is 35.3139, prompting investors to assess its value proposition.